Detalhe da pesquisa
1.
Mechanisms and disease consequences of nonalcoholic fatty liver disease.
Cell
; 184(10): 2537-2564, 2021 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33989548
2.
ER Stress Drives Lipogenesis and Steatohepatitis via Caspase-2 Activation of S1P.
Cell
; 175(1): 133-145.e15, 2018 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30220454
3.
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis.
N Engl J Med
; 390(6): 497-509, 2024 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38324483
4.
Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH.
N Engl J Med
; 389(11): 998-1008, 2023 Sep 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37356033
5.
Fazirsiran for Liver Disease Associated with Alpha1-Antitrypsin Deficiency.
N Engl J Med
; 387(6): 514-524, 2022 08 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35748699
6.
Metabolic dysfunction-associated steatotic liver disease: Update and impact of new nomenclature on the American Association for the Study of Liver Diseases practice guidance on nonalcoholic fatty liver disease.
Hepatology
; 79(5): 1212-1219, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38445559
7.
Epidemiology, screening, and Co-management of type 2 diabetes mellitus and Metabolic-dysfunction associated steatotic liver disease.
Hepatology
; 2024 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38722246
8.
Validation of AGA clinical care pathway and AASLD practice guidance for nonalcoholic fatty liver disease in a prospective cohort of patients with type 2 diabetes.
Hepatology
; 79(5): 1098-1106, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37862551
9.
PNPLA3 rs738409, age, diabetes, sex, and advanced fibrosis jointly contribute to the risk of major adverse liver outcomes in metabolic-associated steatotic liver disease.
Hepatology
; 2024 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38652636
10.
MASH Resolution Index: development and validation of a non-invasive score to detect histological resolution of MASH.
Gut
; 2024 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38418210
11.
New Nomenclature for Nonalcoholic Fatty Liver Disease: Understanding Metabolic Dysfunction-Associated Steatotic Liver Disease, Metabolic Dysfunction- and Alcohol-Associated Liver Disease, and Their Implications in Clinical Practice.
Semin Liver Dis
; 44(1): 35-42, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38531378
12.
Artificial intelligence-assisted digital pathology for non-alcoholic steatohepatitis: current status and future directions.
J Hepatol
; 80(2): 335-351, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37879461
13.
Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease.
J Hepatol
; 80(3): 419-430, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37984709
14.
Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease.
N Engl J Med
; 385(17): 1559-1569, 2021 10 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34670043
15.
A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH.
N Engl J Med
; 385(17): 1547-1558, 2021 10 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34670042
16.
Development and Validation of the Nonalcoholic Fatty Liver Disease Familial Risk Score to Detect Advanced Fibrosis: A Prospective, Multicenter Study.
Clin Gastroenterol Hepatol
; 22(1): 81-90.e4, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37406954
17.
Age, BMI, and Type 2 Diabetes Modify the Relationship Between PNPLA3 and Advanced Fibrosis in Children and Adults With NAFLD.
Clin Gastroenterol Hepatol
; 22(5): 1024-1036.e2, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38145725
18.
Fibrosis Progression Rate in Biopsy-Proven Nonalcoholic Fatty Liver Disease Among People With Diabetes Versus People Without Diabetes: A Multicenter Study.
Gastroenterology
; 165(2): 463-472.e5, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37127100
19.
Pegbelfermin in Patients With Nonalcoholic Steatohepatitis and Stage 3 Fibrosis (FALCON 1): A Randomized Phase 2b Study.
Clin Gastroenterol Hepatol
; 22(1): 102-112.e9, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37088457
20.
Pegbelfermin in Patients With Nonalcoholic Steatohepatitis and Compensated Cirrhosis (FALCON 2): A Randomized Phase 2b Study.
Clin Gastroenterol Hepatol
; 22(1): 113-123.e9, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37088458